Product Code: RP-ID-10265667 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10265667
Market Overview:
Global Cell Lysis/Cell Fractionation Market Size study, by Product (Consumables, Instruments) By Type of Cell (Mammalian Cells, Microbial Cells, Other Cells) By End User (Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, Others) and Regional Forecasts 2019-2026
Global Cell Lysis/Cell Fractionation Market is valued approximately USD 2.8 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 10.30% over the forecast period 2019-2026. Cell lysis or cell fractionation is the initial step in cell fractionation, protein extraction, organelle isolation and purification. This process is used to split cellular components while conserving specific functions of each component. Increasing Government Funding for Research
coupled with high Prevalence of Diseases are key driving forces of market growth. For instance, as per the WHO, chronic diseases are the leading cause of death globally. For instance, as per the aforementioned source, Ischemic heart diseases was responsible for about 9.43 million death in 2016. Whereas, all cardiovascular diseases are responsible for about 17.9 million deaths annually globally. Further, expanding biotechnology and biopharmaceutical industries and growing focus on personalized medicine is expected to create significant growth opportunity in the market over the forecast period. However, high cost of cell-based research impedes the growth of the market over the forecast period of 2019-2026.
The regional analysis of global Cell Lysis/Cell Fractionation market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing ageing population coupled with rising government funding in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as substantial research in the development of the nucleic acid derived products, considerable healthcare expenditure and significant population base would create lucrative growth prospects for the Cell Lysis/Cell Fractionation market across Asia-Pacific region.
Major market player included in this report are:
Thermo Fisher Scientific, Inc.
Merck KGAA
Bio-Rad Laboratories, Inc.
Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
Becton, Dickinson and Company
Cell Signaling Technology, Inc.
Miltenyi Biotec
Roche Diagnostics (A Division of F. Hoffmann–La Roche Ltd.)
Qiagen N.V.
Qsonica, LLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Consumables
Instruments
By Type of Cell:
Mammalian Cells
Microbial Cells
Other Cells
By END USER:
Research Laboratories and Institutes
Biopharmaceutical and Biotechnology Companies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Cell Lysis/Cell Fractionation Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Merck KGAA
Bio-Rad Laboratories, Inc.
Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
Becton, Dickinson and Company
Cell Signaling Technology, Inc.
Miltenyi Biotec
Roche Diagnostics (A Division of F. Hoffmann–La Roche Ltd.)
Qiagen N.V.
Qsonica, LLC
Related Reports
Proof of Quality & Reliability
